The company
BIO-key International, Inc.
BKYI · Nasdaq
BKYI stood above a rising 150-day average in 2 of the last 52 weekly readings, and has been out of that trend for the last 46 weeks. It is 37.7% below that average now. Software: 42% of its 234 stocks in an uptrend (+4 points in four weeks); Technology: 29% (−3 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 46
- Industry in uptrend
- 42% +4 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $0
- Officials’ trades on record
- 0
- Institutions holding
- 0 (-9)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 2 of 52 weeks.
Software: About half its stocks are in an uptrend and the share has been climbing. Technology: A minority of its stocks are in an uptrend and the share has been slipping.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
No open-market buy or sale by its insiders on record.
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|
News
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.